These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31295857)

  • 1. Comparable Bioavailability and Disposition of Pefloxacin in Patients with Cystic Fibrosis and Healthy Volunteers Assessed via Population Pharmacokinetics.
    Bulitta JB; Jiao Y; Landersdorfer CB; Sutaria DS; Tao X; Shin E; Höhl R; Holzgrabe U; Stephan U; Sörgel F
    Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31295857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First population pharmacokinetic analysis showing increased quinolone metabolite formation and clearance in patients with cystic fibrosis compared to healthy volunteers.
    Jiao Y; Kim TH; Tao X; Kinzig M; Landersdorfer CB; Drescher SK; Sutaria DS; Moya B; Holzgrabe U; Sörgel F; Bulitta JB
    Eur J Pharm Sci; 2018 Oct; 123():416-428. PubMed ID: 30076955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparable population pharmacokinetics and pharmacodynamic breakpoints of cefpirome in cystic fibrosis patients and healthy volunteers.
    Bulitta JB; Kinzig M; Landersdorfer CB; Holzgrabe U; Stephan U; Sörgel F
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2927-36. PubMed ID: 21402834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Population Pharmacokinetic Approach to Explain the Differences between Cystic Fibrosis Patients and Healthy Volunteers via Protein Binding.
    Shah NR; Bulitta JB; Kinzig M; Landersdorfer CB; Jiao Y; Sutaria DS; Tao X; Höhl R; Holzgrabe U; Kees F; Stephan U; Sörgel F
    Pharmaceutics; 2019 Jun; 11(6):. PubMed ID: 31216743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of pefloxacin after repeated intravenous and oral administration (400 mg bid) in young healthy volunteers.
    Frydman AM; Le Roux Y; Lefebvre MA; Djebbar F; Fourtillan JB; Gaillot J
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():65-79. PubMed ID: 3458699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four Decades of β-Lactam Antibiotic Pharmacokinetics in Cystic Fibrosis.
    Bulitta JB; Jiao Y; Drescher SK; Oliver A; Louie A; Moya B; Tao X; Wittau M; Tsuji BT; Zavascki AP; Shin BS; Drusano GL; Sörgel F; Landersdorfer CB
    Clin Pharmacokinet; 2019 Feb; 58(2):143-156. PubMed ID: 29936678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefepime pharmacokinetics in cystic fibrosis.
    Hamelin BA; Moore N; Knupp CA; Ruel M; Vallée F; LeBel M
    Pharmacotherapy; 1993; 13(5):465-70. PubMed ID: 8247913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics in Patients with Cystic Fibrosis: A Systematic Review of Data Published Between 1999 and 2019.
    De Sutter PJ; Gasthuys E; Van Braeckel E; Schelstraete P; Van Biervliet S; Van Bocxlaer J; Vermeulen A
    Clin Pharmacokinet; 2020 Dec; 59(12):1551-1573. PubMed ID: 32808233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ketoprofen (NSAID) on the pharmacokinetics of pefloxacin and ofloxacin in healthy volunteers.
    Fillastre JP; Leroy A; Borsa-Lebas F; Etienne I; Gy C; Humbert G
    Drugs Exp Clin Res; 1992; 18(11-12):487-92. PubMed ID: 1308475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absolute oral bioavailability of rosuvastatin in healthy white adult male volunteers.
    Martin PD; Warwick MJ; Dane AL; Brindley C; Short T
    Clin Ther; 2003 Oct; 25(10):2553-63. PubMed ID: 14667956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinolone disposition in the elderly. Practical implications.
    Nilsson-Ehle I; Ljungberg B
    Drugs Aging; 1991; 1(4):279-88. PubMed ID: 1794020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion and bactericidal activities of a single oral dose of 400 milligrams of fleroxacin versus a single oral dose of 800 milligrams of pefloxacin in healthy volunteers.
    Naber KG; Theuretzbacher U; Kinzig M; Savov O; Sörgel F
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1659-65. PubMed ID: 9661000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of Tedizolid in Plasma and Sputum of Adults with Cystic Fibrosis.
    Park AYJ; Wang J; Jayne J; Fukushima L; Rao AP; D'Argenio DZ; Beringer PM
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report: pharmacokinetic and drug interaction studies of pefloxacin with paracetamol (NNAID) in healthy volunteers in Pakistan.
    Gauhar S; Ali SA; Naqvi SB; Shoaib MH
    Pak J Pharm Sci; 2014 Mar; 27(2):389-95. PubMed ID: 24577931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased nonrenal clearance and increased diuretic efficiency of furosemide in cystic fibrosis.
    Alván G; Beermann B; Hjelte L; Lind M; Lindholm A; Strandvik B
    Clin Pharmacol Ther; 1988 Oct; 44(4):436-41. PubMed ID: 3168395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute bioavailability, pharmacokinetics, and urinary excretion of the novel antimigraine agent almotriptan in healthy male volunteers.
    Jansat JM; Costa J; Salvà P; Fernandez FJ; Martinez-Tobed A
    J Clin Pharmacol; 2002 Dec; 42(12):1303-10. PubMed ID: 12463724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the pharmacokinetics and pharmacodynamic profile of carumonam in cystic fibrosis patients and healthy volunteers.
    Bulitta JB; Duffull SB; Landersdorfer CB; Kinzig M; Holzgrabe U; Stephan U; Drusano GL; Sörgel F
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):130-41. PubMed ID: 19748423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloxacillin absorption and disposition in cystic fibrosis.
    Spino M; Chai RP; Isles AF; Thiessen JJ; Tesoro A; Gold R; MacLeod SM
    J Pediatr; 1984 Nov; 105(5):829-35. PubMed ID: 6502318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered prednisolone pharmacokinetics in patients with cystic fibrosis.
    Dove AM; Szefler SJ; Hill MR; Jusko WJ; Larsen GL; Accurso FJ
    J Pediatr; 1992 May; 120(5):789-94. PubMed ID: 1578318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of rifampin on the pharmacokinetics of pefloxacin.
    Humbert G; Brumpt I; Montay G; Le Liboux A; Frydman A; Borsa-Lebas F; Moore N
    Clin Pharmacol Ther; 1991 Dec; 50(6):682-7. PubMed ID: 1752112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.